◆ 会议时间：2023年12月14-16日
◆ 会议地点：中国、上海

◆ 会议简介：

第十八届亚太高血压学术会议(APCH 2023)、2023中国高血压年会、第25届国际高血压及相关疾病学术研讨会将于2023年12月14-16日在中国上海举行，会议由亚太高血压学会(APSH)、中国高血压联盟、北京高血压防治协会、上海市高血压研究所联合主办。

亚太高血压学会(APSH)成立于1997年，是国际高血压学会(ISH)在亚太区域的官方附属机构。APSH是亚洲国家高血压学会或心脏学会高血压部门的联合会，APSH成立的宗旨是促进对高血压的临床和科学认识，提高对高血压及相关血管疾病的治疗水平。APSH首届会议于1999年在印度尼西亚巴厘岛举行，之后每两年召开一次（未经本站许可，禁止复制转载镜像本站任何内容—领域国际医学会议网）。

18th Congress of the Asian Pacific Society of Hypertension (APCH2023) 

Date: 14-16 December 2023
Venue: 上海龙之梦万丽酒店（上海长宁区长宁路1018号）, Shanghai, China

摘要征文投稿截止日期：2023年8月5日

投稿/注册或了解更多会议相关信息请进入官网：www.apch2023.cn

Dear Friends and Colleagues,

On behalf of the Organizing and Scientific Committees, it is our great pleasure to welcome you to attend the 18th Congress of the Asian Pacific Society of Hypertension (APCH) which will be held in Shanghai on 14-16 December 2023.

The meeting will cover a large area of knowledge on hypertension and related diseases such as stoke, dyslipidemia, diabetes mellitus, obesity, obstructive sleep apnea, coronary heart disease, heart failure, atrial fibrillation and new antithrombotics, peripheral arterial diseases, etc. We believe that the meeting will provide a full update of the most important achievements in the above topics over the past years.

Distinguished national and international scientists will be invited to share their groundbreaking research, present their original scientific research, and clinicians will debate the hottest topics for daily practice. The meeting will be a great opportunity to learn, to participate and to interact with those who are at the forefront of hypertension and related diseases.

We look forward to welcoming you to the meeting.

Jiguang Wang, MD, PhD 
Chairman of APCH 2023
President of Chinese Hypertension League
Professor of Cardiovascular Medicine 
Director, The Shanghai Institute of Hypertension 
Director, Department of Hypertension
Director, Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Jiaotong University School of Medicine

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。